Health ministry buys 300 mn doses of Biological-E’s Covid vaccine in advance

The RBD protein sub-unit vaccine, which is currently undergoing Phase III clinical trials, is likely to be available in the next few months
Representational Image. (Shutterstock)
Representational Image. (Shutterstock)
Published on Jun 03, 2021 09:14 AM IST
Copy Link

The Centre has finalised arrangements with Hyderabad-based vaccine manufacturer, Biological-E, to reserve 300 million Coronavirus disease (Covid-19) vaccine doses, Union ministry of health and family welfare announced on Thursday.

“These vaccine doses will be manufactured and stockpiled by M/s Biological-E from August-December 2021. For this purpose, the Union Ministry of Health would be making an advance payment of 1,500 crore to M/s Biological-E,” a statement by the ministry said.

The RBD protein sub-unit vaccine, which is currently undergoing Phase III clinical trials, is likely to be available in the next few months.

Also Read | All doctors put in one category due to war-like situation during pandemic: HC

“The arrangement with M/s Biological-E is part of the wider endeavour of Government of India to encourage indigenous vaccine manufacturers by providing them support in Research & Development (R&D) and also financial support,” the statement read.

The vaccine candidate has been supported by Government of India since the pre-clinical stage. The department of biotechnology not only provided financial assistance in terms of grant-in-aid of over 100 crore but has also partnered with Biological-E to conduct all animal challenge and assay studies through its Research Institute Translational Health Science Technology Institute, Faridabad (Haryana).

According to the ministry, the aid is a part of government of India’s “Mission COVID Suraksha- the Indian COVID-19 Vaccine Development Mission” that aims to bring a safe, efficacious, affordable, and accessible Covid-19 vaccine.

The mission is currently supporting the development of five-six Covid-19 vaccine candidates, and some of these are now close to license and introduction in public health systems.

SHARE THIS ARTICLE ON
  • ABOUT THE AUTHOR

    Rhythma Kaul works as an assistant editor at Hindustan Times. She covers health and related topics, including ministry of health and family welfare, government of India.

Close Story
SHARE
Story Saved
×
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Monday, June 27, 2022